Poxviruses are distinguished from other eucaryotic DNA viruses in that all stages of viral replication occur in virosomes or micronuclei in the cytoplasm of infected cells (reviewed in references 9 and 18). Despite the fact that members of this virus group do not physically enter the cell nucleus during their replicative cycle, certain poxviruses have been recognized for many years as causative agents for a number of proliferative diseases. Three notable examples of such tumorigenic poxviruses are (i) Shope fibroma virus (SFV), which induces benign fibromas in adult rabbits (22) and invasive atypical fibrosarcomas in both newborn rabbits (1, 21, 23, 26) and immunosuppressed adult rabbits (2, 23) ; (ii) Yaba tumor virus, found to cause subcutaneous histiocytomas in monkeys and humans (3); and (iii) molluscum contagiosum virus, which causes benign tumorlike epidermal lesions in humans (7) . Most of what little is known about the proliferative response induced by some members of the poxvirus family has come from classical biological studies of SFV-infected rabbits (reviewed in reference 11). At present it is unclear how, at the molecular level, SFV induces proliferation of target fibroblasts or the viral gene products which presumably mediate this response. However, it has been shown recently that vaccinia virus, a cytolytic poxvirus of the genus Orthopoxvirus, encodes a gene product designated vaccinia growth factor (VGF), which shares amino acid homology with epidermal growth factor (EGF) and transforming growth factor alpha (TGFa) (5, 6, 19) . These polypeptide growth factors bind to the EGF receptor on the cell surface and lead to the phosphorylation of the receptor in a process which eventually triggers cellular proliferation (reviewed in references 12, 13, 15, 17, and 20 ). Here we demonstrate that SFV also encodes a related gene product which possesses significant homology with the EGF family of growth factors.
To detect the growth factor gene of SFV, we used degenerate oligonucleotides as probes in hybridization studies. A region of seven amino acids (a.a.'s 75 to 81) in VGF was chosen for the design of the oligonucleotide probes (Fig. 1) . The a.a. sequences in this region constitute a part of the cysteine loop which is highly conserved among the EGF * Corresponding author. family of growth factors. A pool of oligonucleotides (YC-1) was synthesized by using an Applied Biosystems 380A synthesizer, according to the preferred codon usage of vaccinia virus, to include 128-fold degeneracy (as described in legend to Fig. 1 ) in the nucleotide sequences encoding VGF in this region. Using a 32P-end-labeled YC-1 probe, we screened the cloned BamHI library of the SFV genome (30) by dot blot analysis, under washing conditions of 6x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate [pH 7]) at 370 for 1 h, and found that the BamHI C fragment contained sequences homologous to the growth factor family (Fig. 2i) . The other faint signals (Fig. 2iA) were not reproducibly observed and represent background signals of
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YC-1 pool: Fig. 2iii . Results from this experiment indicate that the homology was located within a 2.3-kb region between the restriction sites for BglI at 13.5 kb and SmaI at 10.8 kb on the SFV map (4, 8, 10) .
Since the probe YC-1 did not hybridize to BamHI fragments IT, 0, and E which contain the SFV terminal inverted repeat (TIR) sequences plus unique internal sequences from the left end of the SFV genome (10), this placed the SFV growth factor (SFGF) gene within the internal unique sequences at the right end of the SFV genome, between the BglI site and the junction with the viral TIR (Fig. 2iii) . This is in contrast with the location of the VGF gene, which was within the TIR of the vaccinia genome.
To further characterize this region of the SFV genome which was homologous to the VGF gene, we subcloned the 2.3-kb BglI-SmaI fragment into M13, mp18, and mp19 and determined the nucleotide sequence from the BglI site to the boundary between the viral TIR and the unique internal sequence (Fig. 3) , using exonuclease III-derived deletions as templates by the method of Sanger (4, 28, 29) . Computer analysis revealed a single complete open reading frame capable of encoding a growth-factor-like polypeptide which is 80 a.a.'s in length. In addition, the sequence data revealed a portion of open reading frame T9-R, a recently described SFV gene which maps almost entirely in the viral TIR except for the N-terminal 50 a.a.'s, which are encoded in the unique internal sequences at the right end of the viral genome (29) . This result confirmed the proximity of the SFGF gene to the unique internal sequence-TIR sequence junction as had been indicated by the Southern blot analysis.
The SFGF gene is quite A+T rich (64%), a common feature of many poxvirus genes. The DNA sequence AATATAAA upstream of the presumptive initiating ATG codon for both SFGF and open reading frame T9-R (Fig. 3 ) is also present upstream of VGF and several other SFV genes (29) . The role of this conserved region in the expression of the SFGF gene in SFV is currently under investigation. By Northern blot analysis we detected SFGF expression as early as 2 h after SFV infection of CV-1 cells (data not shown). This indicates that the SFGF may be expressed as an early gene product during SFV infection, as is VGF during vaccinia infection.
The location of the SFGF gene within the unique SFV sequences adjacent to the right viral TIR is highly significant. A recently discovered tumorigenic leporipoxvirus, malignant rabbit fibroma virus (MRV), has been shown to be a recombinant between myxoma virus, the agent of myxomatosis, and SFV (4). MRV is of particular interest because it induces fibromas in infected rabbits that at early periods are indistinguishable from those induced by SFV. Mapping and sequencing studies (4, 29) indicate that only 5 to 7 kb of sequences derived in large part from the SFV TIR region have been transferred by genetic recombination into a myxoma virus genetic background to generate the recombinant MRV genome. Since this stretch of SFV DNA transferred to MRV includes an intact SFGF gene (C. Upton, J. Macen, and G. McFadden, manuscript in preparation), the putative SFGF protein would clearly be a candidate mediator of tumorigenicity for both MRV and SFV.
The deduced sequence of SFGF was compared with that of EGF, TGFa, and VGF (Fig. 4) . Of the 13 conserved tyrosine, cysteine, glycine, and arginine residues characteristic of this growth factor family, 12 residues were retained in the SFGF sequence. More importantly, the six cysteine residues which form the three disulfide bridges critical for proper folding in EGF and TGFa were all conserved in SFGF. Only one of the cysteine loops of SFGF (13 residues, from a.a.'s 47 to 61) was different in size from the corresponding loop of EGF, TGFa, and VGF, which are all 10 a.a.'s in length. In the highly conserved stretch from a.a.'s 33 to 77 of SFGF, more than 50% of the a.a. residues in the SFV sequence had an identical counterpart in at least one of the other three growth factors. Perhaps the most striking feature of the SFGF sequence was the lack of any obvious hydrophobic cluster at the C-terminus which could direct the putative polypeptide to a membrane-associated location. In fact, the entire 80-a.a. SFGF is very similar in size to the secreted form of the VGF precursor, which cleaves at residues 20 and 96 to yield a 77-a.a. extracellular polypeptide (25) . At the N-terminal end of the SFGF gene there is a hydrophobic sequence from a.a.'s 6 to 17 which is reminiscent of the signal sequence of secreted proteins. However, it remains to be determined whether SFGF is cleaved and secreted like its vaccinia virus counterpart. Inspection of all open reading frames both upstream and downstream from the SFGF gene did not reveal any obvious sequence homologies to the precursor sequences cleaved from EGF, TGFa, or VGF proteins before secretion. Thus, the evolutionary origin of SFGF with respect to these growth factors cannot as yet be ascertained. (Fig. 3) is indicated at the bottom. VOL. 7, 1987 on Comparison of the SFGF a.a. sequence with other members of the EGF-TGFa family. The 80-a.a. sequence of the SFGF sequence is compared with the vaccinia strain WR VGF precursor, and the secreted peptides in rat TGFa (rTGFax), mouse EGF (mEGF), and human EGF (hEGF) (5, 6) . Identical residues are indicated in blocks. The proposed N-terminal signal sequence and hydrophobic C-terminal membrane spanning site of the VGF are underlined (6) , and the deduced cleavage sites for the generation of the secreted polypeptide derived from the VGF precursor (25) are indicated by arrows.
The role of EGF-TGFa-like growth factors in the poxvirus life cycle is still unclear (24) . VGF purified from the supernatant of vaccinia virus-infected cells binds to EGF receptors and can stimulate the tyrosine kinase activity of these receptors in a manner analogous to that induced by EGF or TGF;x (16, 27) . Our results indicate that the presence of a growth-factor-like gene may be a common feature of the poxvirus family. The question of whether the characteristic proliferative responses induced by the tumorigenic poxviruses such as SFV are in fact mediated by this growth factor may now be addressed directly by in vitro mutagenesis in this region of the viral genome.
